acti posts
FeedPosted Dec 31st 2008 12:15PM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations
.gif)
Analyst upgrades:
- Empire District Electric (NYSE:EDE) was upgraded to Buy from Hold at Jefferies on valuation. The firm raised its target to $18.50 from $16.
- Actividentity (NASDAQ:ACTI) was upgraded to Buy from Hold at Soleil and its target was increased to $3.25 from $2.50 on valuation.
- Merrill upgraded Phototronics (NASDAQ:PLAB) to Buy from Underperform citing cost reductions, the amended credit agreement, and expectations for growth after the January quarter.
Analyst downgrades:
- Roth Capital downgraded RTI Biologics (NASDAQ:RTIX) to Hold from Buy and lowered its target to $3 from $6 following its negative Q4 negative pre-announcement.
- Morgan Joseph said Ceradyne (NASDAQ:CRDN) will not ship any new X-SAPI body armor in Q4 due to a contract protest by a competitor. The Army has decided to seek new bids but CRDN management expects to win a similar order in late January with deliveries expected in late 1Q09. Shares were downgraded to Hold from Buy.
Analyst initiations:
- William Blair initiated Grand Canyon (NASDAQ:LOPE) with an Outperform rating. The firm believes the company has strong growth prospects amid a favorable industry backdrop.
- Keefe Bruyette resumed coverage of Assured Guaranty (NYSE:AGO) with a Market Perform rating and $12.50 target, citing financial guaranty market instability.
- Capital Source (NYSE:CSE) was reinstated with a Neutral rating at Credit Suisse.
- Yongye Biotechnology (OTC:YGYB) was initiated with a Buy rating and $3.50 target at Roth Capital.
Why isn't Bank of America updating its shareholders on CEO situation?
Before the bell: Futures sharply lower on Dubai's debt problems
Will Rich Ross really have a positive impact on Disney's movie operations?
